Entera Bio (ENTX) Other Working Capital Changes (2021 - 2026)
Entera Bio's (ENTX) quarterly Other Working Capital Changes came in at $94000.0 in Q1 2026, down 71.77% YoY from $333000.0 in Q1 2025, and up 840.0% on a QoQ basis from $10000.0 in Q4 2025.
Entera Bio (ENTX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Entera Bio (ENTX) has 6 years of Other Working Capital Changes data on file, last reported at $94000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 89.51% year-over-year to -$15000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$15000.0 (up 89.51% YoY) and the FY2022 annual result came in at -$15000.0, up 89.51% from the prior year.
- Other Working Capital Changes eased to -$15000.0 in Q1 2022, from $15000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $15000.0 in Q4 2021 to a low of -$143000.0 in Q1 2021.
- A 5-year average of $18882.4 and a median of -$33000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes tumbled 2966.67% — and 2025, when it surged 135.71%.
- Tracing ENTX's Other Working Capital Changes over 2 years: stood at $15000.0 in 2021, then slumped by 200.0% to -$15000.0 in 2022.
- The last three Other Working Capital Changes figures came in at -$15000.0 (Q1 2022), $15000.0 (Q4 2021), and -$8000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Entera Bio | 162.96 Mn | 151.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46,000.00 |
| Jun 30, 2026 | -46,000.00 |
| Jun 30, 2026 | -46,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Dec 31, 2024 | -28,000.00 |